Key Market Segments:
By Polymer Type
-
Polydioxanone
-
Elastomer
-
Polyethylene Terephthalate
-
Others
By Application
-
Aortic Disease
-
Peripheral Artery Disease
-
Hemodialysis
By End-Users
-
Hospitals
-
Cardiac Catheterization Laboratories
-
Ambulatory Surgical Centers
-
Specialty Clinics
-
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
-
US
-
Canada
-
Mexico
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Turkey
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Singapore
-
Australia
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g., Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
The Artificial Blood Vessels Market was valued at USD 2.38 billion in 2025 and is projected to reach USD 4.02 billion by 2035, growing at a CAGR of 5.38% from 2026 to 2035.
Artificial blood vessels, also called synthetic vascular grafts, are used to restore blood flow in patients with arterial blockages, aneurysms, peripheral artery disease, and for hemodialysis access procedures.
Market growth is driven by the rising prevalence of cardiovascular diseases, increasing vascular surgeries, growing aging population, and technological advancements in biomaterials and polymer-based vascular grafts.
North America holds the largest market share due to advanced healthcare infrastructure, high cardiovascular surgery rates, and the strong presence of leading medical device manufacturers.
The hospitals segment dominates the market, accounting for about 54.27% share in 2025, as most complex vascular surgeries and graft implantation procedures are performed in hospital settings.
Get in touch
